Embolism: Clinical Trials

43 trials for Embolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed. 43 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 443Completed 43

Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
Thrombolytic, Standard anticoagulation - Pulmonary Embolism
Phase 4CompletedFaculty Hospital Kralovske Vinohrady5582022-10-192026-11-06
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Anticoagulation with heparin, EkoSonicTM Endovascular System - Pulmonary Embolism
Phase 4CompletedBoston Scientific Corporation5442021-08-022026-11-16
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Apixaban 2.5 MG, Placebo oral tablet - Deep Vein Thrombosis, Pulmonary Embolism
Phase 4CompletedBrigham and Women's Hospital6002021-03-012025-11-14
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
Enoxaparin - COVID, Thrombosis
Phase 4CompletedCentral Hospital, Nancy, France10002020-05-132023-08-07
Direct Mechanical Thrombectomy Versus Bridging Therapy
Trevo and or Merci devices for stent retreival, Penumbra system for stent aspiration, recombinant tissue plasminogen activator - Thrombectomy, Ischemic Stroke
Phase 4CompletedAlexandria University512019-07-012022-01-03
Chemoprophylaxis Plus Early Ambulation
Chemoprophylaxis with Low Molecular Weight Heparin (LMWH) - Pulmonary Embolism, Thoracic Surgery
Phase 4CompletedShen Lei5812017-08-082021-11-02
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
Enteric Coated Aspirin, Warfarin, Rivaroxaban - Pulmonary Embolism, Venous Thrombosis
Phase 4CompletedDartmouth-Hitchcock Medical Center188832016-12-012026-10-05
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery
Enoxaparin - Venous Thromboembolism, Pulmonary Embolism
Phase 4CompletedTampere University Hospital852016-05-012023-05-09
Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive
Furosemide, NaCl 9% isotonic - Pulmonary Embolism
Phase 4CompletedCentre Hospitalier Universitaire de Nice602015-12-232020-09-25
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Apixaban, Standard of Care - Venous Thromboembolism
Phase 4CompletedBristol-Myers Squibb2292015-11-222024-10-29
A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
Rivaroxaban, Standard-of-care - Pulmonary Embolism
Phase 4CompletedJanssen Scientific Affairs, LLC1142015-10-152018-06-01
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Ekosonic® Endovascular Device ultrasonic infusion catheter, Recombinant tissue plasminogen activator - Pulmonary Embolism and Thrombosis
Phase 4CompletedBoston Scientific Corporation1312015-06-122021-07-19
NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
NAC, NaHCO3, Normal Saline - Radiographic Contrast Agent Nephropathy, Pulmonary Embolism
Phase 4CompletedKaradeniz Technical University2312014-02-012015-06-26
Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Rivaroxaban or Marcumar - Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT)
Phase 4CompletedRWTH Aachen University1922013-07-012020-10-22
Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Rivaroxaban, Fluindione, Warfarin - Permanent Atrial Fibrillation, Venous Thrombosis
Phase 4CompletedUniversity Hospital, Angers512013-05-212019-11-07
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Low dose nadroparin, Intermediate dose nadroparin, Low dose enoxaparin - Deep Venous Thrombosis, Pulmonary Embolism
Phase 4CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)11102013-04-242022-05-26
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
5000 Units unfractionated Heparin Q 8 hr, 30mg enoxaparin Q12 hr - Venous Thromboembolic Disease, Deep Vein Thrombosis
Phase 4CompletedScripps Health4952012-11-012016-07-18
Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
Actilyse (Thrombolytic therapy), Heparine (Standard anticoagulation therapy) - Pulmonary Embolism
Phase 4CompletedUniversity Hospital Ostrava1002011-03-012018-03-19
Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
Dalteparin - Superficial Thrombophlebitis
Phase 4CompletedUniversity Medical Centre Ljubljana682010-12-012018-05-04
Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism
Evaluation of a modified DD cut-off to rule out PE - Pulmonary Embolism
Phase 4CompletedMarc Righini33062010-10-012015-05-28

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Pulmonary Embolism (39)  ·  Venous Thrombosis (15)  ·  Thrombosis (8)  ·  Venous Thromboembolism (8)  ·  Atrial Fibrillation (5)  ·  Thromboembolism (4)  ·  Ischemic Stroke (2)  ·  Stroke (2)  ·  Antiphospholipid Syndrome (1)  ·  Hematoma (1)  ·  Hemorrhage (1)  ·  Ischemia (1)  ·  Lung Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Cardiovascular Diseases (43)  ·  Embolism and Thrombosis (43)  ·  Vascular Diseases (42)  ·  Lung Diseases (39)  ·  Respiratory Tract Diseases (39)  ·  Thrombosis (13)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Thromboembolism (7)  ·  Heart Diseases (6)  ·  Arrhythmias, Cardiac (5)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)

Interventions

Dalteparin (5)  ·  Heparin, Low-Molecular-Weight (5)  ·  Enoxaparin (4)  ·  Rivaroxaban (4)  ·  Tissue Plasminogen Activator (4)  ·  Heparin (3)  ·  Nadroparin (3)  ·  Tinzaparin (3)  ·  Warfarin (3)  ·  Acetylcysteine (2)  ·  Aspirin (2)  ·  Fibrinolytic Agents (2)  ·  Phenprocoumon (2)  ·  Standard of Care (2)  ·  Urokinase-Type Plasminogen Activator (2)

Sponsors

Beijing Chao Yang Hospital (4)  ·  Boston Scientific Corporation (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Alexandria University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda Ospedaliera Universitaria Policlinico (1)  ·  Bracco Diagnostics, Inc (1)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  British Thoracic Society (1)  ·  Cantonal Hospital of St. Gallen (1)  ·  Central Hospital, Nancy, France (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Complejo Hospitalario Xeral-Calde (1)

Countries

United States (12)  ·  France (10)  ·  China (5)  ·  Canada (4)  ·  Germany (4)  ·  Netherlands (4)  ·  Spain (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Switzerland (3)  ·  Czechia (2)  ·  Finland (2)  ·  Ireland (2)  ·  Russia (2)  ·  Turkey (Türkiye) (2)

Top investigators

Alejandro Veres Racamonde, MD (1)  ·  Aziz Sheikh, MD,FRCGP (1)  ·  Bob Smouse, MD (1)  ·  Carol A Lambourne, PhD (1)  ·  Christopher J. Destache, Pharm. D. (1)  ·  Dean T Yamaguchi, MD, PhD (1)  ·  El Mehdi Siaghy (1)  ·  Gening Jiang (1)

Results publications

PMID 17065639, PMID 17289685, PMID 18656008, PMID 19741062, PMID 20040086, PMID 20352167, PMID 20353588, PMID 20553388, PMID 23299853, PMID 23306310, PMID 24135533, PMID 24643601, PMID 24768093, PMID 24807875, PMID 24876082, PMID 25900749, PMID 25903529, PMID 25919526, PMID 27411777, PMID 30025734, PMID 31926776, PMID 33337539, PMID 33502773, PMID 33779986, PMID 34622445, PMID 34878173, PMID 35244208, PMID 35381867, PMID 35588898, PMID 36303136, PMID 36354038, PMID 36695396, PMID 37350990, PMID 37977307, PMID 40888734, PMID 41910345, PMID 42392108, PMID 42678032

NIH funding

2014 (1), 2016 (1)